A Fed rate hike will affect the supply and demand in the stock market, says Miller Tabak equity strategist Matt Maley. » Read More
Merrimack Pharmaceuticals develops products to treat cancer. President and CEO Bob Mulroy, shares his view of drug price hikes and whether the FDA is in the way of companies.
Barbara Mistick, author of "Stretch," a book about taking responsibility of your career, discusses the changing job world.
Rep. Jason Chaffetz (R-Utah), Chairman of the House Oversight & Government Committee, comments on former Turing Pharmaceuticals CEO Martin Shkreli's tweet calling the Congressional committee "imbeciles."
Warren Buffett has acquired another 1.69 million shares of Phillips 66, reports CNBC's Seema Mody.
"Power Lunch" hosts Melissa Lee and Brian Sullivan look at 5 stocks with analyst recommendations, including Jefferies saying Therapeutics MD will double.
Rep. Jason Chaffetz (R-Utah), Chairman of the House Oversight & Government Committee, reflects on former Turing Pharmaceuticals CEO Martin Shkreli's behavior on Capitol Hill, and the debate on drug prices and the role of government.
CNBC's Michelle Caruso-Cabrera explains the fear over Deutsche Bank's debt.
In a webcast on emerging markets, IMF managing director Christine Lagarde addressed China's economic direction.
TD Ameritrade CEO Fred Tomczyk, says investors are very active in their portfolio amid volatility, in discussing the impact of Fed policy.
Stocks are doing something rare on Thursday: Nothing.
CNBC's Eamon Javers reports on government involvement in drug prices.
Bullish case for homebuilding stocks.
Gold was near a three-month top after its best day in two weeks, buoyed by hopes the Federal Reserve won't raise interest rates this year.
ConocoPhillips on Thursday reported a loss that was larger than analysts' has expected and cut its quarterly dividend.
Saira Malik, head of global active equity portfolio management for TIAA-CREF, is using the pullback in the market this year to get long a group of stocks.
Oppenheimer analyst Jason Helfstein and David Katz of Matrix Asset Advisors discuss concerns impacting Facebook, Amazon, Netflix and Google's shares.
CNBC's Jackie DeAngelis offers reasons why crude prices are rising, including a weakened dollar and more talk of an OPEC meeting.
David Miller of Topeka Capital Markets and James Marsh of Piper Jaffray offer their takes on where Dreamworks' shares will be headed this year.
Italian coast guard rescues 11 migrants, Toyota to discontinue Scion brand after slumping sales, Bernie Sanders to get Secret Service protection.
CNBC's Bob Pisani explains the factors that are sending S&P higher.